Innovation at UVA: Where New Inventions Promise to be Useful, Improve Human Health & Life Experiences

Date & Time

October 15, 2016 @ 10:00 am - 11:00 am


Alumni Hall Ballroom
211 Emmet Street South
Charlottesville, VA



From novel medical imaging to the Internet of Things, from the artificial pancreas to improved water purification—faculty, staff and students at the University of Virginia are innovating every day.  Michael Straightiff, Executive Director, UVA Licensing & Ventures Group, will be joined by several innovators to discuss their developments and how innovation at UVA enriches the student experience, provides opportunities for researchers and alumni, catalyzes economic development and, most importantly, improves human health and the human experience.


Michael P. Straightiff

Executive Director, UVA Licensing & Ventures Group

Michael Straightiff, Executive Director, University of Virginia Licensing and Ventures Group, holds a B.S.E. in biomedical engineering and an M.B.A. from Case Western Reserve University and an M.P.P. in Science and Technology Policy from George Mason University. He has worked as a patent examiner at the United States Patent and Trademark Office and in early-stage technology commercialization at Case Western Reserve University and Virginia Tech. Michael joined the UVA Licensing & Ventures Group as its Executive Director in 2011.

James Landers

Commonwealth Professor in the Departments of Chemistry, Mechanical Engineering and Pathology

James Landers is the Commonwealth Professor in the Departments of Chemistry, Mechanical Engineering and Pathology at the University of Virginia

Director, MicroGEM

MicroGEM is an enabler of proven science and technology, delivering cost-effective, value-added manufacturing and distribution solutions to forensic, diagnostic, agricultural and horticultural markets.

Chad Rogers

CEO, TypeZero

TypeZero Technologies is developing algorithmic and software technologies to deliver major improvements in the management of insulin-dependent diabetes. The company is working to commercialize Artificial Pancreas solutions for patients with Type 1 diabetes as well as applications and cloud based analytical services to patients with Type 1 and Type 2 diabetes which will optimize therapies, reduce treatment inefficiencies and improve outcomes.

Erik Breuhaus

Business Development and Operations, PsiKick

Erik Breuhaus works in business operations & strategy at PsiKick, a self-powering Internet of Things systems company. In that role, he directly supports the CEO and management team in a variety of roles, including customer engagement, recruiting, operations, and financial management. Erik joined PsiKick after completing his MBA at the Darden School of Business at the University of Virginia (D’14). While at Darden, Erik worked as a commercialization consultant for Springbok, an early stage sports analytics company commercializing a novel MRI technology to improve athletic health and performance.